BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 32694637)

  • 1. Robust performance of deep learning for distinguishing glioblastoma from single brain metastasis using radiomic features: model development and validation.
    Bae S; An C; Ahn SS; Kim H; Han K; Kim SW; Park JE; Kim HS; Lee SK
    Sci Rep; 2020 Jul; 10(1):12110. PubMed ID: 32694637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Machine learning-based radiomic evaluation of treatment response prediction in glioblastoma.
    Patel M; Zhan J; Natarajan K; Flintham R; Davies N; Sanghera P; Grist J; Duddalwar V; Peet A; Sawlani V
    Clin Radiol; 2021 Aug; 76(8):628.e17-628.e27. PubMed ID: 33941364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IDH1 mutation prediction using MR-based radiomics in glioblastoma: comparison between manual and fully automated deep learning-based approach of tumor segmentation.
    Choi Y; Nam Y; Lee YS; Kim J; Ahn KJ; Jang J; Shin NY; Kim BS; Jeon SS
    Eur J Radiol; 2020 Jul; 128():109031. PubMed ID: 32417712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of supratentorial single brain metastasis and glioblastoma by using peri-enhancing oedema region-derived radiomic features and multiple classifiers.
    Dong F; Li Q; Jiang B; Zhu X; Zeng Q; Huang P; Chen S; Zhang M
    Eur Radiol; 2020 May; 30(5):3015-3022. PubMed ID: 32006166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffusion radiomics as a diagnostic model for atypical manifestation of primary central nervous system lymphoma: development and multicenter external validation.
    Kang D; Park JE; Kim YH; Kim JH; Oh JY; Kim J; Kim Y; Kim ST; Kim HS
    Neuro Oncol; 2018 Aug; 20(9):1251-1261. PubMed ID: 29438500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of glioblastoma from solitary brain metastases using radiomic machine-learning classifiers.
    Qian Z; Li Y; Wang Y; Li L; Li R; Wang K; Li S; Tang K; Zhang C; Fan X; Chen B; Li W
    Cancer Lett; 2019 Jun; 451():128-135. PubMed ID: 30878526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fully automated radiomics-based machine learning models for multiclass classification of single brain tumors: Glioblastoma, lymphoma, and metastasis.
    Joo B; Ahn SS; An C; Han K; Choi D; Kim H; Park JE; Kim HS; Lee SK
    J Neuroradiol; 2023 Jun; 50(4):388-395. PubMed ID: 36370829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Validation of a Deep Learning-Based Model to Distinguish Glioblastoma from Solitary Brain Metastasis Using Conventional MR Images.
    Shin I; Kim H; Ahn SS; Sohn B; Bae S; Park JE; Kim HS; Lee SK
    AJNR Am J Neuroradiol; 2021 May; 42(5):838-844. PubMed ID: 33737268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a multi-modality fusion deep learning model for differentiating glioblastoma from solitary brain metastases.
    Shen S; Li C; Fan Y; Lu S; Yan Z; Liu H; Zhou H; Zhang Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2024 Jan; 49(1):58-67. PubMed ID: 38615167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinguishing brain abscess from necrotic glioblastoma using MRI-based intranodular radiomic features and peritumoral edema/tumor volume ratio.
    Xiao D; Wang J; Wang X; Fu P; Zhao H; Yan P; Jiang X
    J Integr Neurosci; 2021 Sep; 20(3):623-634. PubMed ID: 34645095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-enhanced T1-weighted image radiomics of brain metastases may predict EGFR mutation status in primary lung cancer.
    Ahn SJ; Kwon H; Yang JJ; Park M; Cha YJ; Suh SH; Lee JM
    Sci Rep; 2020 Jun; 10(1):8905. PubMed ID: 32483122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary central nervous system lymphoma and atypical glioblastoma: Differentiation using radiomics approach.
    Suh HB; Choi YS; Bae S; Ahn SS; Chang JH; Kang SG; Kim EH; Kim SH; Lee SK
    Eur Radiol; 2018 Sep; 28(9):3832-3839. PubMed ID: 29626238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A radiomics-based model to differentiate glioblastoma from solitary brain metastases.
    Su CQ; Chen XT; Duan SF; Zhang JX; You YP; Lu SS; Hong XN
    Clin Radiol; 2021 Aug; 76(8):629.e11-629.e18. PubMed ID: 34092362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiomic features and multilayer perceptron network classifier: a robust MRI classification strategy for distinguishing glioblastoma from primary central nervous system lymphoma.
    Yun J; Park JE; Lee H; Ham S; Kim N; Kim HS
    Sci Rep; 2019 Apr; 9(1):5746. PubMed ID: 30952930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Machine-learning based radiogenomics analysis of MRI features and metagenes in glioblastoma multiforme patients with different survival time.
    Liao X; Cai B; Tian B; Luo Y; Song W; Li Y
    J Cell Mol Med; 2019 Jun; 23(6):4375-4385. PubMed ID: 31001929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion and perfusion MRI radiomics obtained from deep learning segmentation provides reproducible and comparable diagnostic model to human in post-treatment glioblastoma.
    Park JE; Ham S; Kim HS; Park SY; Yun J; Lee H; Choi SH; Kim N
    Eur Radiol; 2021 May; 31(5):3127-3137. PubMed ID: 33128598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiomics features to distinguish glioblastoma from primary central nervous system lymphoma on multi-parametric MRI.
    Kim Y; Cho HH; Kim ST; Park H; Nam D; Kong DS
    Neuroradiology; 2018 Dec; 60(12):1297-1305. PubMed ID: 30232517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation between glioblastoma, brain metastasis and subtypes using radiomics analysis.
    Artzi M; Bressler I; Ben Bashat D
    J Magn Reson Imaging; 2019 Aug; 50(2):519-528. PubMed ID: 30635952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporating diffusion- and perfusion-weighted MRI into a radiomics model improves diagnostic performance for pseudoprogression in glioblastoma patients.
    Kim JY; Park JE; Jo Y; Shim WH; Nam SJ; Kim JH; Yoo RE; Choi SH; Kim HS
    Neuro Oncol; 2019 Feb; 21(3):404-414. PubMed ID: 30107606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Machine learning-based radiomic, clinical and semantic feature analysis for predicting overall survival and MGMT promoter methylation status in patients with glioblastoma.
    Lu Y; Patel M; Natarajan K; Ughratdar I; Sanghera P; Jena R; Watts C; Sawlani V
    Magn Reson Imaging; 2020 Dec; 74():161-170. PubMed ID: 32980505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.